Learn More
Medchemexpress LLC N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide | 1208319-26-9 | MFCD25976611 | 99.6% | C15H23N5O2S | 10MG

Supplier: Medchemexpress LLC HY1357710MG
Oclacitinib is a research-grade small-molecule Janus kinase (JAK) inhibitor most potent against JAK1 (IC50 10 nM). It is provided as a high-purity powder for preclinical and biochemical studies of cytokine-mediated signaling, allergic responses, and inflammatory pathways. Documentation such as a datasheet and certificate of analysis are available to support experimental use.
- Selective JAK1 inhibition with IC50 10 nM.
- Suitable for cellular and biochemical assays probing cytokine signaling.
- High purity (≈99.6%) for reproducible results.
- Supplied as a powder with recommended long-term storage at -20°C.
- Datasheet and certificate of analysis available for quality assurance.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.